Stifel Nicolaus Analyst W. Andrew Carter has status a to buy Rating on Aurora Cannabis (ACB) on April 2nd and set a target price of C $ 6.00. The company’s shares closed at $ 13.75 last Wednesday.
Carter has an average return of 12.4% if you recommend Aurora Cannabis.
According to TipRanks.com, Carter ranks 3545 out of 7271 analysts.
Aurora Cannabis has an analyst consensus from Moderate Sell with a target price consensus of $ 8.82, a -33.3% decrease from current levels. In a report released May 13, Cantor Fitzgerald also maintained a buy rating on the stock with a target price of $ 22.00.
See Today’s Analyst’s Top Recommended Stocks >>
Based on Aurora Cannabis’ most recent earnings release for the quarter ended September 30, the company reported quarterly revenue of $ 67.81 million and a GAAP net loss of $ 108 million. By comparison, the company had revenues of $ 73.71 million and net income of $ 9.82 million last year.
TipRanks has tracked 36,000 company insiders and found that some of them are better than others when it comes to the timing of their transactions. See which 3 stocks are most likely to move after their inside activity.
Aurora Cannabis, Inc. is engaged in the manufacture, distribution and sale of cannabis products. The company also manufactures and sells indoor growing systems and hemp products. The company was founded on December 21, 2006 by Terry Booth and Steve Dobler and is headquartered in Edmonton, Canada.
Read more about ACB: